leukemia immune evasion in relapse after haploidentical hematopoietic cell transplantation
Published 4 years ago • 304 plays • Length 2:36Download video MP4
Download video MP3
Similar videos
-
3:38
epigenetic deregulation in relapsed leukemia
-
2:06
managing relapsed all: the role of novel cellular therapies & importance of conditioning regimens
-
2:22
using epigenetic strategies to combat relapse in patients with leukemia
-
2:16
phase i study of donor-derived γδ t cells as relapse prophylaxis post haplo/cy
-
2:38
emerging strategies for the management of relapsed aml
-
3:25
how have leukemia diagnostics and management evolved?
-
1:39
germline predisposition to clonal hematopoiesis and its role in leukemia progression
-
14:44
the role of allosct in patients with hl who relapse after autosct and the impact of novel agents
-
9:34
important topics from the mpn congress 2024: addressing the risk of transformation to acute leukemia
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
3:18
granulocytes & t-cells as biomarkers for relapse in cml following discontinuation of tkis
-
1:59
understanding the biology behind aml relapse
-
1:19
the outcomes of patients with primary refractory and relapsed acute leukemia
-
1:16
how novel immunotherapies have impacted the treatment of r/r all
-
0:49
systemic treatment outcomes in relapsed/refractory poems syndrome
-
1:41
developing novel gene therapy approaches for hemoglobinopathies
-
1:22
the importance of finding strategies to prevent relapse of acute myeloid leukemia (aml)
-
2:05
donor lymphocyte infusion for relapsed myelofibrosis in the post-allosct setting
-
1:25
hellstrand lab leukemia research: exploring immune escape and defining therapeutic targets
-
2:22
the treatment of relapsed/refractory chronic lymphocytic leukemia
-
4:43
novel treatments being explored for patients with hemophilia: highlights from isth 2024